680 related articles for article (PubMed ID: 12415026)
1. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone and 17beta-oestradiol treatment on metabolism and body composition in girls with Turner syndrome.
Gravholt CH; Hjerrild BE; Naeraa RW; Engbaek F; Mosekilde L; Christiansen JS
Clin Endocrinol (Oxf); 2005 May; 62(5):616-22. PubMed ID: 15853835
[TBL] [Abstract][Full Text] [Related]
3. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome.
Ari M; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4302-5. PubMed ID: 16940444
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
5. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
6. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
7. Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.
Wooten N; Bakalov VK; Hill S; Bondy CA
J Clin Endocrinol Metab; 2008 Jun; 93(6):2109-14. PubMed ID: 18349057
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
[TBL] [Abstract][Full Text] [Related]
9. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study.
Naeraa RW; Gravholt CH; Kastrup KW; Svenstrup B; Christiansen JS
Acta Paediatr; 2001 May; 90(5):526-31. PubMed ID: 11430712
[TBL] [Abstract][Full Text] [Related]
10. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules.
Gravholt CH; Hjerrild BE; Mosekilde L; Hansen TK; Rasmussen LM; Frystyk J; Flyvbjerg A; Christiansen JS
Eur J Endocrinol; 2006 Oct; 155(4):583-92. PubMed ID: 16990658
[TBL] [Abstract][Full Text] [Related]
11. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
12. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
13. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; Aanstoot HJ; Drop SL
J Clin Endocrinol Metab; 2000 Feb; 85(2):769-75. PubMed ID: 10690889
[TBL] [Abstract][Full Text] [Related]
15. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
[TBL] [Abstract][Full Text] [Related]
16. The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome.
Gravholt CH; Leth-Larsen R; Lauridsen AL; Thiel S; Hansen TK; Holmskov U; Naeraa RW; Christiansen JS
Eur J Endocrinol; 2004 Mar; 150(3):355-62. PubMed ID: 15012622
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial.
Kuppens RJ; Bakker NE; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Donze SH; Festen DA; van Alfen-van der Velden JA; Stijnen T; Hokken-Koelega AC
J Clin Endocrinol Metab; 2016 Nov; 101(11):4110-4116. PubMed ID: 27552545
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
Khorram O; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
Sääf M; Hilding A; Thorën M; Troell S; Hall K
Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
[TBL] [Abstract][Full Text] [Related]
20. Turner syndrome, insulin sensitivity and growth hormone treatment.
Mazzanti L; Bergamaschi R; Castiglioni L; Zappulla F; Pirazzoli P; Cicognani A
Horm Res; 2005; 64 Suppl 3():51-7. PubMed ID: 16439845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
